Antoun has more than 15 years of executive business development experience in the financial, biotech and pharmaceutical sectors.
Antoun joined Raptor Pharmaceuticals, Inc. in October 2014 as Vice President of Corporate Development, overseeing licensing and other strategic transactions. Prior to joining Raptor, he served at Capnia, Inc. as VP of Corporate Development, managing their November 2014 IPO. Before Capnia, Mr. Nabhan was a Senior Director in Onyx Pharmaceuticals’ Corporate Development and Strategy group. Prior to Onyx, Mr. Nabhan was a founding executive of two private biotechnology companies, Presidio Pharmaceuticals, Inc. and Incellico, Inc., and served as a Principal with Sagamore Bioventures, investing professionally in private and public biotechnology companies.
Mr. Nabhan received a B.A. from the University of Chicago and a J.D. from Harvard Law School. He is a member of the California State Bar and has served on the Board of Directors of BayBio, Presidio Pharmaceuticals, and Cellerant, Inc.